Purchase of an Illumina MiSeq i100 plus

The contract involves the purchase of an Illumina MiSeq i100 plus, a next-generation sequencing instrument with enhanced capabilities for detecting pathogens in seafood. This acquisition supports the Food and Drug Administration's initiative for culture-independent pathogen identification and is essential for developing rapid long-read sequencing methods. These methods will enable real-time screening of pathogens in environmental field samples, improving the ability to monitor and respond to contamination risks swiftly. The contract is categorized under NAICS code 541990 and is forecasted by the FDA, although specific solicitation and location details have not yet been determined. Key contacts for this procurement include a program liaison reachable via email and a contracting officer position that remains to be assigned. This equipment is part of a broader effort to enhance pathogen detection technologies critical to food safety and public health surveillance.